mitoxantrone has been researched along with DDPAC in 1 studies
Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brown, DG | 1 |
| Shorter, J | 1 |
| Wobst, HJ | 1 |
1 review available for mitoxantrone and DDPAC
| Article | Year |
|---|---|
Emerging small-molecule therapeutic approaches for amyotrophic lateral sclerosis and frontotemporal dementia.
Topics: Amyotrophic Lateral Sclerosis; Autophagy; C9orf72 Protein; DNA-Binding Proteins; Frontotemporal Deme | 2020 |